REQUEST A DEMO
Total
USD $0.00
Search more companies

Tci Gene Inc. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tci Gene Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Tci Gene Inc. is mainly engaged in the R & D and manufacturing of various gene testing, stem cell and immune cell products, providing customized services for gene testing and personal health care, and human stem cell therapy services. The company's main products include gene testing services, virus detection services, cell experiment services, stem cell-based medicinal products, production of natural killer cell, personalized gene health food, etc. The company was established in 2011 and is headquartered in Taipei, Taiwan.

Headquarters
10F., No. 185-1, Gangqian Rd, Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Tci Gene Inc. report to view the information.

Website: http://www.genext.me

Basic Information
Total Employees:
Purchase the Tci Gene Inc. report to view the information.
Outstanding Shares:
Purchase the Tci Gene Inc. report to view the information.
Financial Auditors:
Purchase the Tci Gene Inc. report to view the information.
Incorporation Date:
July 13, 2011
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
41.94%
Purchase this report to view the information.
17.84%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Glux Hk Limited (Hong Kong SAR, China)
100%
大江生活股份有限公司
79.31%
Company Performance
Financial values in the chart are available after Tci Gene Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
9.77%
Total operating revenue
8.44%
Operating profit (EBIT)
1660.78%
EBITDA
16.44%
Net Profit (Loss) for the Period
89.57%
Total assets
1.62%
Total equity
8.46%
Operating Profit Margin (ROS)
17.45%
Net Profit Margin
5.91%
Return on Equity (ROE)
0.93%
Quick Ratio
1.93%
Cash Ratio
-2.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?